Overlap of International League of Associations for Rheumatology and Preliminary Pediatric Rheumatology International Trials Organization Classification Criteria for Nonsystemic Juvenile Idiopathic Arthritis in an Established UK Multicentre Inception Cohort

Objective The goal was to assess the degree of overlap between existing International League of Associations for Rheumatology (ILAR) and preliminary Paediatric Rheumatology International Trials Organisation (PRINTO) classification criteria for juvenile idiopathic arthritis (JIA). Methods Participant...

Full description

Saved in:
Bibliographic Details
Published in:Arthritis care & research (2010) Vol. 76; no. 6; pp. 831 - 840
Main Authors: Shoop‐Worrall, Stephanie J. W., Macintyre, Vanessa G., Ciurtin, Coziana, Cleary, Gavin, McErlane, Flora, Wedderburn, Lucy R., Chieng, Alice, Baildam, Eileen, Foster, Helen, Davidson, Joyce, Ioannou, Yiannis, Hyrich, Kimme L.
Format: Journal Article
Language:English
Published: Boston, USA Wiley Periodicals, Inc 01-06-2024
Wiley Subscription Services, Inc
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective The goal was to assess the degree of overlap between existing International League of Associations for Rheumatology (ILAR) and preliminary Paediatric Rheumatology International Trials Organisation (PRINTO) classification criteria for juvenile idiopathic arthritis (JIA). Methods Participants from the Childhood Arthritis Prospective Study, a multicenter UK JIA inception cohort, were classified using the PRINTO and ILAR classification criteria into distinct categories. Systemic JIA was excluded because several classification items were not collected in this cohort. Adaptations to PRINTO criteria were required to apply to a UK health care setting, including limiting the number of blood biomarker tests required. The overlap between categories under the two systems was determined, and any differences in characteristics between groups were described. Results A total of 1,223 children and young people with a physician’s diagnosis of JIA were included. Using PRINTO criteria, the majority of the patients had “other JIA” (69.5%). There was a high degree of overlap (91%) between the PRINTO enthesitis/spondylitis‐ and ILAR enthesitis‐related JIA categories. The PRINTO rheumatoid factor (RF)–positive category was composed of 48% ILAR RF‐positive polyarthritis and 52% undifferentiated JIA. The early‐onset antinuclear antibodies–positive PRINTO category was largely composed of ILAR oligoarthritis (50%), RF‐negative polyarthritis (24%), and undifferentiated JIA (23%). A few patients were unclassified under PRINTO (n = 3) and would previously have been classified as enthesitis‐related JIA (n = 1) and undifferentiated JIA (n = 2) under ILAR. Conclusion Under the preliminary PRINTO classification criteria for childhood arthritis, most children are not yet classified into a named category. These data can help support further delineation of the PRINTO criteria to ensure homogenous groups of children can be identified.
Bibliography:Supported by Versus Arthritis (UK grant 20542). Dr Shoop‐Worrall's work was supported by the Medical Research Council (grant MR/W027151/1). Drs Ciurtin and Wedderburn's work was supported by the Centre for Adolescent Rheumatology Versus Arthritis at University College London, University College London Hospital, and Great Ormond Street Hospital (GOSH) (UK grant 20164, 21593). Dr Wedderburn's work was supported by the NIHR Biomedical Research Centre at GOSH and for the Childhood arthritis and its associated Uveitis: Stratification through Endotypes and mechanism to deliver benefit consortium, by the Medical Research Council (grant MR/R013926/1), Versus Arthritis (UK grant 22084), Great Ormond Street Hospital Children's Charity (grant VS0518) and Olivia's Vision. Dr Hyrich's work was supported by Versus Arthritis Centre for Epidemiology (UK grant 21755) and by the NIHR Manchester Biomedical Research Centre. This report includes independent research funded by the NIHR Biomedical Research Centre Funding Scheme.
https://onlinelibrary.wiley.com/doi/10.1002/acr.25296
The views expressed herein are those of the authors and do not necessarily represent those of the NHS, the National Institute of Health Research (NIHR), or the Department of Health.
Authors Shoop‐Worrall and MacIntyre contributed equally to this work.
.
Author disclosures are available at
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2151-464X
2151-4658
2151-4658
DOI:10.1002/acr.25296